Evidence map›Paper›PMID 27243827›Full record

ArticlePloS one2016

Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection.

Ednelza da Silva Graça Amoras, Samara Tatielle Monteiro Gomes, Felipe Bonfim Freitas, Bárbara Brasil Santana, Geraldo Ishak, Marialva Tereza Ferreira de Araújo, Sâmia Demachki, Simone Regina Souza da Silva Conde, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The -Frontiers in immunology · 2018
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ednelza da Silva Graça AmorasLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Samara Tatielle Monteiro GomesLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Felipe Bonfim FreitasLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Bárbara Brasil SantanaLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Geraldo IshakJoão de Barros Barreto Hospital, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Marialva Tereza Ferreira de AraújoSchool of Medicine, Institute of Health Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Sâmia DemachkiSchool of Medicine, Institute of Health Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Simone Regina Souza da Silva CondeSchool of Medicine, Institute of Health Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Marluísa de Oliveira Guimarães IshakLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Ricardo IshakLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Antonio Carlos Rosário VallinotoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará (Universidade Federal do Pará -UFPA), Belém, Pará, Brazil.
Universidade Federal do Pará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThis study aimed to evaluate the relative mRNA expression of Fas receptor (FAS), Fas ligand (FASL), and forkhead box protein 3 (FOXP3) in liver biopsy specimens obtained from patients with viral and non-viral chronic hepatitis and correlate their expression with the fibrosis stage. A total of 51 liver biopsy specimens obtained from HBV (n = 6), HCV (n = 28), and non-viral hepatic disease (NVHD) (n = 9) patients and from individuals with normal liver histology (n = 8) (control-CT) were analyzed. Quantifications of the target genes were assessed using qPCR, and liver biopsies according to the METAVIR classification. The mRNA expression levels of FAS and FASL were lower in the CT group compared to the groups of patients. The increase in the mRNA expression of FAS and FASL was correlated with higher levels of inflammation and disease progression, followed by a decline in tissues with cirrhosis, and it was also associated with increased levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Higher mRNA expression of FOXP3 was observed in the HCV and NVHD groups, with the peak observed among patients with cirrhosis. The increased FOXP3 mRNA expression was positively correlated with increased FAS and FASL mRNA expression and the AST and ALT levels in all patients.

conclusionsThese results suggest that regardless of the cause, the course of chronic liver disease may be modulated by the analyzed genes and correlated with an increase in regulatory T cells during the liver damage followed by hepatocyte destruction by Fas/FasL system and subsequent non specific lymphocytic infiltrate accumulation.

Indexed as

Alanine TransaminaseApoptosisAspartate AminotransferasesBiopsyCD4 Lymphocyte CountFas Ligand Proteinfas ReceptorForkhead Transcription FactorsHepacivirusHepatitis C, ChronicHepatocytesHumansLiverLiver CirrhosisPolymerase Chain ReactionRNA, MessengerAlanine TransaminaseAspartate AminotransferasesFASLG protein, humanFas Ligand Proteinfas ReceptorForkhead Transcription FactorsFOXP3 protein, humanRNA, Messenger

Identifiers

PMID27243827
PMCPMC4887037
OpenAlexW2419480295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.